UCLA Health researchers say study findings uncover Huntington's disease mechanisms and pave new ways to develop treatments.

Huntington's disease is a rare genetic, autosomal dominant, neurodegenerative disease, caused by CAG repeat expansions in the HTT gene, that is polymorphic on the healthy allele and contains more than ...

Woman currently in jail for social welfare fraud is now subject of new theft and fraud offences Garda investigation ...

ALZcure is pioneering blockchain-powered funding for Alzheimer's research through Decentralized Science (DeSci). Built on ...

Biosciences presented data from the KINECT-HD study showcasing significant improvements in chorea across body regions with ...

Prilenia Therapeutics is planning to file its Huntington’s disease therapy pridopidine in the EU, despite mixed results in a phase 3 trial. Pridopidine is an oral agonist of the S1R protein ...

ZyVersa Therapeutics (NASDAQ:ZVSA – Get Free Report) is expected to be announcing its earnings results before the market ...

What initially seems like purely psychological trouble may indeed have roots in physical conditions that, once identified, ...

Its potential in Huntington's disease emerged thanks to an AI drug screening platform operated by SOM, which is used to identify existing drugs that can be repurposed for use in new indications.

Just as cities must carefully manage the flow of cars in and out of downtown, cells regulate the movement of molecules into ...

Just as cities must carefully manage the flow of cars in and out of downtown, cells regulate the movement of molecules into and out of the nucleus.